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INTRODUCTION
The rapid development of functional nanomaterials has enabled many advances in diagnostics, bioimaging and drug delivery in the past decades. [1, 2] Nanoparticles (NPs) grafted with specific polymers such as polyethylene glycol (PEG) become suspended in the aqueous phase and biocompatible. PEGylation also discourages protein fouling as the polymer layer acts as an entropic spring to fend off the surface adsorption of biomolecules. Collectively, these features have consolidated PEGylation as a 'gold standard' for surface functionalization in biomedical and engineering applications. [3] It is well established that NPs readily adsorb a 'corona' [4] [5] [6] [7] of proteins upon introduction into a biological milieu, a phenomenon resulting from hydrophobic, electrostatic and van der Waals interactions as well as hydrogen bonding between the NPs and proteins in the fluid environment. The transformation from bare NPs to NP-protein complexes usually confers the NPs with improved suspendability and a new biological identity that drives in vivo interactions and clearance of the NPs. [8, 9] Binding with NPs could also impact the conformation of adsorbed proteins, thereby inducing exposure of new epitopes and potentially altering protein function. For example, activated phagocyte recognition of a protein corona via enriched complement components may lead to decreased systemic retention for a particular NP, [10, 11] a characteristic undesirable for drug delivery. Accordingly, surface functionalization to incorporate 'stealth' polymers is a logical solution to minimize and control the protein corona for effective design and targeted delivery of nanomedicines. [12] PEG is by far the most commonly used polymer for creating 'stealth' NPs. However, PEG is not biodegradable and the in vivo accumulation of PEGylated therapeutics can cause the production of anti-PEG antibodies to accelerate blood clearance and severe hypersensitivity reactions following administration. [3, [13] [14] [15] [16] [17] [18] In addition, the heavily crowded patent landscape of PEG has also triggered intensive search for alternative stealth polymers. [19] [20] [21] Poly(2-oxazoline)s (POx) are an emerging class of polymers, [22] which provide access to highly functional polymers with tuneable properties simply by changing their side chain. [23, 24] The possibility to introduce functional groups at the α-, and ω-polymer chain ends and, contrary to PEG, in the side chains makes POx available for a wide range of post-polymerization modifications, [23, 25] which can be exploited, e.g. for high drug loadings in polymer-drug conjugates. [26] In particular, the short homologues poly(2-methyl-2-oxazoline) (PMeOx) and poly(2-ethyl-2-oxazoline) (PEtOx) have been demonstrated to be valuable alternatives to PEG with similar water-solubility, biocompatibility and stealth/protein repellent properties. [27] Moreover, PMeOx and PEtOx offer potential benefits over PEG, including (i) relatively low viscosities of their aqueous solutions, (ii) depending on molecular mass, they can be excreted in urine and have so far yet to show accumulations in organs, and (iii) they are considered non-immunogenic and to date no POx-antibodies in human populations have been reported. [28] In terms of their interaction with proteins, limited studies performed with full serum have only looked into the mass deposition of proteins rather than the detailed composition of protein corona. [29, 30] One recent study has examined the antifouling capacity of poly(organosiloxane) (POS)
NPs grafted with linear PEG and PEtOx exposed to fetal calf serum. [31] However, an in-depth comparison of the stealth performance and protein corona profile of PEtOx versus PEG against human plasma proteins remains lacking despite the large number of studies into POx-based particles for biomedical applications and the high relevance of such data for the development of nanomedicine and bionanotechnology. [32] Furthermore, research on the protein corona has almost exclusively adopted spherical or cylindrical NPs, overlooking the importance of NP shape in determining corona formation. Nano-graphene oxide (nGO), specifically, is a one-atom thin, 2D nanomaterial with small lateral dimensions and a large surface area. nGO possesses exceptional electronic, photothermal and mechanical properties and has found many biomedical applications. [33] [34] [35] [36] [37] [38] [39] Here we detail the human plasma protein association of a novel nanomaterial, PEtOx-grafted nGO (nGO-PEtOx), in comparison with that of PEG-grafted nGO (nGO-PEG). Liquid chromatography coupled to mass spectrometry (LC-MS/MS) was used post synthesis for label-free quantitation (LFQ) of proteins present in the NP protein coronas. Although both nGO-PEG and nGO-PEtOx exhibited superior antifouling compared to bare nGO, they were each associated with different subsets of plasma proteins essential to major physiological functions. In addition to the comparable corona profiles observed for high abundance opsonins, there was a significant enrichment of apolipoproteins (APOA1/A2/C1/A4/H, CLU) for nGO-PEG, and pro-angiogenic, structural and acute-phase plasma proteins for nGO-PEtOx, respectively. Together, this study provides the first report on the unique corona proteome in human plasma and in vitro toxicity profiles of nGO-PEG and nGO-PEtOx, implicating PEtOx as a viable stealth polymer alternative to PEG for biomedical and biotechnological applications.
MATERIALS AND METHODS

Materials
A nano-graphene oxide (nGO, ~50×100 nm in lateral dimensions) suspension was obtained from Sigma-Aldrich. PEG and PEtOx polymers with amine end groups (MW: 2,000 g/mol) were synthesized according to protocols described previously. [40, 41] The polymers were designed to have the same molecular weight in order to minimize any size-induced variability. All other chemicals were obtained from Sigma-Aldrich and used as received unless otherwise specified.
NMR spectroscopy
Nuclear magnetic resonance (NMR) spectra were recorded using a Bruker UltraShield 400 spectrometer running Bruker Topspin, version 1.3 and operating at 400. 
Size exclusion chromatography
DMAc size exclusion chromatography (SEC) was performed using a Shimazu modular system consisting of a SIL20AD automatic injector, a DGU12A degasser, a CTO10A column oven, a LC10AT pump, a RID10A differential refractive-index detector, and a SPD10A Shimadzu UV/Vis detector. A 50×7.8 mm guard column followed by three KF-805L columns in series (300×8 mm linear columns, bead size: 10 μm, pore size: 5,000 Å maximum) were used for the analyses. N,N'-Dimethylacetamide (DMAc, HPLC grade, 0.03% w/v LiBr) with a flow rate of 1 mL/min and a constant temperature of 50 °C was used as the mobile phase. The samples were filtered through 0.45 μm filters prior to injection. The instrument was calibrated using commercially available linear polystyrene standards (0.5-2,000 kDa, Polymer Laboratories). Chromatograms were processed using Cirrus 2.0 software (Polymer Laboratories).
nGO functionalization procedures
nGO (2 mg/mL) was treated with probe sonication for 5 min in an ice bath to ensure its dispersity.
The first step of the reaction was to convert the OH groups on the nGO surface to -COOH groups via conjugation of acetic acid moieties. NaOH (2.4 g) and chloroacetic acid (2.0 g) were added to the nGO aqueous suspension (10 mL) and bath-sonicated for 5 h. This step functionalized nGO by carboxylation. The carboxylated nGO suspension was then neutralized by repeated washing with Milli-Q water through centrifugation (supernatant was removed after each centrifugation cycle).
Eppendorf centrifuge 5804 was used and set for 10 min and 16,300 g for each washing cycle. Purified 
Thermogravimetric analysis
Thermogravimetric analysis (TGA) measurement was implemented using a PerkinElmer Pyris 1 TGA and Pyris 1 software measuring at a rate of 20 °C/min from 100 °C to 700 °C (hold at 100 °C for 1 min to eliminate water).
Dynamic light scattering and zeta potential
The hydrodynamic sizes and zeta potentials of the nGO suspensions (at 0.1 mg/mL in Milli-Q water)
were acquired at room temperature using a dynamic light scattering device (Zetasizer Nano ZS, Transmission electron microscopy and energy-dispersive X-ray spectroscopy nGO (bare nGO , nGO-PEG and nGO-PEtOx) suspensions at a concentration of 0.1 mg/mL were pipetted onto glow discharged (15 s) 400 mesh copper grids (Formvar film, ProSciTech) and allowed 60 s of adsorption. Excess solution volume was drawn off using filter paper and the grids were washed twice using Milli-Q water, with excess removed. The grids were stained with 1% uranyl acetate for 30 s and excess stain drawn off. The grids were completely air-dried. High resolution imaging and EDX elemental analysis were performed on a Tecnai G2 F20 transmission electron microscope (FEI, Eindhoven, Netherlands) operating at 200 kV. The experiment was repeated three times.
Infrared spectroscopy
Attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectra were generated using a Shimadzu IRTracer 100 FTIR spectrometer with a GladiATR 10 single reflection ATR accessory.
The spectra were acquired in the mid-infrared region of 4,000-800 cm -1 at resolution of 8 cm -1 (512 scans) and analyzed by LabSolution IR software.
Raman spectroscopy
Raman spectra were acquired using an inVia confocal Raman microscope (Renishaw). The three types of nGO (bare, nGO-PEG-and nGO-PEtOx) with or without plasma protein coatings, as well as the plasma protein control in aqueous solution (0.5 mg/mL), were mounted on microscope slides and air-dried. The dried samples were excited by a laser line at 785 nm, with a power of 500 mW. Spectra were stored with in-built WiRE 2.0 software.
Collection and processing of healthy donor human plasma proteins
Details of the method are described in a previous publication. analysis were done using the plasma from the three donors to ensure robust results. The analysis of the abundance of coronal proteins was performed by taking average of the three replicates, and only those that were statistically significant were presented.
Corona formation and isolation
Bare, PEG-and PEtOx-grafted nGO (1 mg/mL) in 10 mM phosphate-buffered saline (PBS) were mixed with plasma proteins to make a final concentration of 0.2 mg/mL in 1 mL suspension. The nGO-plasma mixtures were incubated at 37 °C for 24 h to obtain hard protein coronae. The samples were then centrifuged at 16,300 g for 15 min at room temperature to isolate nGO-'hard' protein corona complexes from the remaining plasma, a common methodology in the field. The supernatant was completely removed and the nGO-protein corona pellets were washed 3× with 10 mM fresh PBS.
Following the washes, 50 μL of 5% β-mercaptoethanol (Sigma-Aldrich) in a 4× reducing loading dye 
In-gel proteolytic digestion, plasma control sample preparation, LC-MS/MS analysis and label-free quantification
The entire region of the gel containing resolved proteins was excised and subjected to an in-gel trypsin digestion procedure, as described previously.
[21] Briefly, peptides were extracted, dried in a SpeedVac, and stored at -20 °C until analysis. On the day of analysis, samples were reconsituted in 20 μL of 2% acetonitrile (ACN), 0.1% formic acid and LC-MS/MS analysis with data-dependent acquisition was carried out as previously described with minor modifications. [42] Reconsituted samples were loaded at a flow rate of 15 μL/min onto a reversed-phase trap column (100 μm × 2 cm), Acclaim
PepMap media (Dionex), which was maintained at a temperature of 40 °C . Peptides were then eluted from the trap column at a flow rate of 0.25 μL/min through a reversed-phase capillary column (75 μm × 50 cm) (LC Packings, Dionex). For label-free proteomic analysis, the HPLC gradient was set to 98 min using a gradient that reached 30% ACN after 63 min, 34% after 66 min, 79.2% after 71 min for 6 min, following which there was an equilibration phase of 20 min at 2% ACN. Peptide sequences (and protein identity) were determined using MaxQuant software (version 1.6.0.1) by matching the human protein database (Homo sapiens, uniprot-proteome_UP000005640.fasta) and label free quantification of identified proteins was then performed as previously described.
[21]
Protein hit filtering methods and significance
Experiments were replicated three times to assess reproducibility. Only proteins detected in three replicates (LFQ intensity > 0) were used for further analyses. LFQ intensity was used to approximate the relative protein abundance between the different types of nGOs, while intensity was used to represent the protein abundance for each type of nGO individually. A student's t-test was used to evaluate the significance of differences observed across the three independent replicates between nGO-PEG and nGO-PEtOx, and p-values < 0.05 were considered significant.
Protein informatics and network annotation
The MaxQuant output (protein_groups.csv) was filtered to remove all proteins with less than one unique peptide, and with zero values for LFQ intensity across the nGO-PEG and nGO-PEtOx experiments. Additional processing included log2 transforms, means, standard deviations, LFQ ratios and t-tests. Protein sequences and annotations were extracted from the UniProt Human proteome (uniprot-proteome_UP000005640.fasta) by matching to protein identifiers in the filtered protein list.
For the matched set of protein sequences, the grand average of hydropathy (GRAVY), isoelectric point (pI), and molecular weight (MW) were calculated. To produce a contextual human plasma proteome background, a non-glycosylated PeptideAtlas build was downloaded (20170801-063918 -to recall the results used, visit this link db.systemsbiology.net/sbeams/cgi/shortURL?key=cga2kglb -provided in supplementary material) and both the protein identifiers and sequences were extracted from the UniProt *.fasta file: GRAVY, pI and MW were calculated for these sequences (as above) and used as a background proteome. The complete R data import, processing and presentation code, as well as session information that includes computer, software and package versions, are detailed in supplementary information. [43, 44] Proteins were submitted for matching of uniprot identifiers to STRING identifiers (http://www.uniprot.org/uploadlists/). The subset of matched STRING identifiers were used for protein network analysis with a whole genome background using the online resource STRING (v10.5, string-DB.org/). [45] Interactions were defined by database and experimentally determined sources at a confidence interaction score of 0.7 (medium). No additional possible interactors were added. Color highlighting was used to emphasize gene ontology (GO) terms enriched by the analysis, and color halos were used to indicate PEG-or PEtOx-enrichment. All plots were formatted further in InkScape (inkscape.org) or used directly.
HEK 293 cell viability assay
For Experiments were conducted in triplicate.
Red blood cell (RBC) haemolysis assay
The haemolysis assay was slightly modified according to previously published protocols. [46, 47] Briefly, freshly drawn healthy human donor blood (50 μL) was added to 1. paraformaldehyde and PBS was replaced by ethanol using gradient dilution from 20% to 100% of ethanol) were mounted on SEM specimen stubs coated with carbon tapes and images were taken using an ORION NanoFab scanning helium ion microscope.
RESULTS AND DISCUSSION
PEG and PEtOx with primary amine end groups (MW ~2000 Da, determined by NMR; Figure S1 , Electronic Supplementary Information or ESI) were successfully synthesized using a two-step reaction according to published protocols (Scheme 1). [40, 41] Size exclusion chromatography (SEC) revealed mono-modal traces with narrow molecular weight distributions for both polymers (Đ, PEtOx = 1.06, PEG = 1.06, Figure S1 ). nGO was first functionalized by carboxylation, and then the two types of polymers were grafted onto the surface of nGO by N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) coupling. [48, 49] The average lateral dimensions (50×100 nm) of bare nGO (carboxylated before polymer grafting) and PEG-and PEtOx-grafted nGO were estimated from TEM images (Figure 1 ). Successful grafting of the polymers was first confirmed using
ATR-FTIR and energy-dispersive X-ray spectroscopy (EDX) (Figures S2 and S3). ATR-FTIR
detected the characteristic chemical bond peaks associated with nGO (e.g. OH stretch at 3,340 cm -1 )
and their attached polymers (e.g., ether bond at 1,100 cm -1 for PEG and amide C=O stretch at 1,630 cm -1 for PEtOx). Although not definitively quantitative, EDX identified nitrogen from the amide bond linking nGO to the polymers (apart from the nitrogen from PEtOx) which also confirmed successful grafting. To precisely quantify the amount of polymers grafted, TGA was performed on the three types of nGO. The grafting density of the polymers was estimated by the percentage weight losses obtained from TGA ( Figure S4 ), where PEG (decomposed from ~307 to 434 °C) and PEtOx (decomposed from ~321 to 473 °C) occupied 31.4% and 29.5% of the total mass of nGO-PEG and nGO-PEtOx, respectively. The hydrodynamic sizes (z-average sizes) and zeta potentials of bare nGO, nGO-PEG and nGO-PEtOx were determined by dynamic light scattering (DLS) ( Table 1 The 10 most abundant proteins for bare nGO, nGO-PEG and nGO-PEtOx coronas, as well as for plasma, are listed in Table 2 . As expected, the abundance distributions of corona proteins associated with the three nGO nanomaterials were different from that of the plasma. For example, serum albumin To more closely evaluate differences in corona composition, unique protein binders were considered.
The Venn diagram in Figure 2a highlights the numbers of proteins which were bound to one, two, or all three nGO types. A total of 17 proteins were unique to one type of nGO, out of which 11 were unique to bare nGO (Table 3 , Figure 2a ). Of the unique nGO-associated proteins, it is worth noting that many were immunoglobulins, which suggests that rapid blood clearance of nGO opsonized by antibodies may occur without a stealth polymer coating: detected immunoglobulins included IGKV2-
(A2NJV5), IGHV6-1 (A0A0B4J1U7), IGKV2-28 (A0A075B6P5), IGLV1-40 (P01703) and
IGLV3-10 (A0A075B6K4) ( Table 3) . (P02747)], making this particle enrichment profile quite distinct from nGO-PEG (Figure 2b , Table   4 ).
A qualitative assessment of calculated -primary sequence specific -characteristics of the corona proteins was also undertaken, including GRAVY, pI and MW. Figure 3 shows the GRAVY/pI distributions (MW/pI in Figure S7 ) for the quantified proteins, with point color representing the foldchange bin to which the log2-normalized ratios of mean PEG: mean PEtOx LFQ intensity value belong. These points were overlaid onto a contextualizing non-glycosylated human plasma protein background from PeptideAtlas. Here, it was assumed that the matched database sequence for the identified protein was identical to that of the nGO-associated protein sequence To further contextualize the relative composition differences of these coronas, a protein network analysis was performed using the STRING resource (string-db.org). This allowed identification of network associations and associated GO terms. Figure 4 highlights the resulting protein network and the colors of the nodes (proteins) indicate enrichment for a particular GO term. Complement activation is highlighted in red as an enriched biological process (BP), enzyme regulator activity is in blue as an enriched GO molecular function (MF), and finally complement and coagulation cascades is in green as an enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. The halos in Figure 4 indicate those protein significantly regulated (see red protein ratios in Figure 2b ), which were enriched on nGO-PEG (yellow) or nGO-PEtOx (black). Both PEG and PEtOx functionalized nGO bound complement components that are part of the coagulation cascade (Figure 4 ). The implication here is that both nanomaterials may be similarly susceptible to reduced biocirculation.
Overall, the split enrichment of different complement and coagulation components by nGO-PEG and nGO-PEtOx, and the over-representation of apolipoproteins by nGO-PEG could have profound implications in vivo following administration of nGO-based nanomedicines, which should be studied in the future. In addition to the proteomic study, HEK 293 cell viability was 51.3±7.1% when exposed to 100 µg/mL of bare nGO (Figure 6a ). However, both PEG-and PEtOx-grafted nGO largely ameliorated the cell viability to above 80%. In contrast, no obvious toxicity was observed for the three types of nGO or the polymers at 50 μg/mL or lower, which confirmed the good biocompatibility of nGO and, in particular, stealth polymer-grafted nGO. The RBC haemolysis assay further revealed that both nGO-PEG and nGO-PEtOx induced negligible damage to cell membranes, while the presence of protein coronas largely mitigated haemolysis induced by nGO, nGO-PEG and nGO-PEtOx at concentrations up to 100 μg/mL (Figure 6b ). Images from helium ion microscopy clearly illustrated haemolytic damage of RBCs induced by bare nGO (Figure 6d) , and the absence of obvious damage in the other samples through the protection of plasma proteins (Figure 6g ) or stealth polymers PEG and PEtOx (Figures 6e,f,h,i) .
CONCLUSION
We have characterized and compared human plasma corona proteome associations of linear PEGand PEtOx-grafted nGO sheets and augmented the examination with viability and haemolysis assays. in chemical adaptability, low viscosity, clearance, and non-immunogenicity, [28] should prove valuable for the continued development of nanomedicine and bionanotechnology. Towards that end, more indepth protein corona studies on POx-grafted particles and surfaces will be necessary in the near future to gain further insights on the biological effects of the stealth polymer. 
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